Screening for prostate cancer--the controversy that refuses to die.
about
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trialsScreening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics StudiesProstate Cancer: Epigenetic Alterations, Risk Factors, and TherapyPredictive and prognostic molecular markers for cancer medicineSANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkersProstate cancer epigenetics and its clinical implicationsA reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.Topologically inferring pathway activity toward precise cancer classification via integrating genomic and metabolomic data: prostate cancer as a case.Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient.Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study.Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancerCancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other CancersMultilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohortEmpirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.Racial differences in PSA screening interval and stage at diagnosis.Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy.Clinical pearls in men's health.Principles of cancer screening: lessons from history and study design issues.From bench to bedside: the realities of reducing global prostate cancer disparity in black men.Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Cancer biomarkers: can we turn recent failures into success?Nanodevices in diagnostics.Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryBlood-based biomarkers of aggressive prostate cancer.MRI-Safe Robot for Endorectal Prostate Biopsy.Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen.Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy.On-capillary fluorescent labeling and capillary electrophoresis laser-induced fluorescence analysis of glycoforms of intact prostate-specific antigen.Translating research to promote healthy aging: the complementary role of longitudinal studies and clinical trials.What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?Biomarkers in the age of omics: time for a systems biology approachThere are calls for a national screening programme for prostate cancer: what is the evidence to justify such a national screening programme?Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer.Decision tree-based modeling of androgen pathway genes and prostate cancer riskMinimal social network effects evident in cancer screening behavior.Decision making and cancer.Screening for prostate cancer: are digital rectal examinations being performed?Application of metabolomics to prostate cancer.
P2860
Q24608493-C92BC9B4-2978-4C5D-BECB-C7308073D8A9Q24620320-21E4EFAC-FFDE-41E6-B99A-B126DA67D159Q26738585-6E39C811-2316-42B3-BB00-B2A5D65D4B0FQ28073470-7782E5B6-B7E6-408E-B120-8060766D1121Q28743108-51227D1F-85A0-42B8-9D5C-48FC422B38CEQ28822547-1AA1CE49-35E8-4B0E-B85D-35A2069ABE7CQ28829460-3DB5D95E-9D7D-40E7-943B-CF82A1057FFBQ30613075-1695725F-2227-4DC6-9F0D-051EF129DB9CQ30988064-1464A104-14A4-4BC6-8510-9AC00EFE6031Q30994622-98B31225-0B15-4CCD-9A09-4EB5F1D062BFQ33519073-FC8B87A4-F8C3-4F00-8711-8F904E547FB1Q33599365-A957A23C-F2A5-4972-BBA5-6ADB580CA650Q33624448-16DA8258-7B7E-44AD-B5D7-F8D77C9E6EDFQ33693397-26927E10-0DAE-44FC-92D4-7C53772A5617Q33820579-D21D7EF8-6044-4222-BE15-30F76FEED962Q33835863-B508D8CB-21DA-465B-A085-E296A7567C2EQ33905826-32ED36F4-2A72-450E-B471-A4567B1D42B3Q33913213-1BB74CFD-654E-4687-926B-4F887F4C3505Q33951568-BACC3064-44EA-4D0C-BACD-E8842D6A5E45Q34065705-E1CD7CD6-5253-4CAE-A1EC-82014EB8EE9CQ34135132-CAAC78AD-D805-4412-94C4-1F67D8CD9F88Q34152258-95E813E3-F13E-4331-BFF3-31EC551C6D4CQ34176379-E6D04556-DA44-4BC4-B418-3EBF5E4017F5Q34234274-A76DD645-B4E5-4A07-BDC3-9BF5135B2A5FQ34239193-395B6839-C207-4E25-A9C9-1145BB1969F4Q34448347-B934B983-E736-4EFD-B2FE-A4A8F67C99E6Q34448754-2B74A02F-7686-4CDE-8D29-0ED16423E677Q34488959-74E3C746-7E23-4812-AE38-7EA2D97B4A3DQ34565363-CA93762B-A6DF-43CA-9B12-EF0D683ABEFDQ34666337-2673C5A2-863B-44DE-9662-A5766384160FQ34675587-8F382730-F8E1-4443-A01B-0F26A27C55DAQ34679360-F150EB18-AF7D-4D3E-99CE-851CB0FFC21FQ34692190-981B367B-8AA4-4098-AA44-CCAA01E1AC35Q34752288-F1EE668A-6622-4010-BAA7-762D6A1FFC97Q34964029-D0F2A3BD-E34C-453C-9328-F19C3E8915E8Q35036697-C9BD52C6-1B13-49EF-8895-30B46298FC4FQ35059049-7B9BB6C8-477F-4444-BE8F-6453759BB48DQ35142194-C4C397B3-F620-405D-869E-3926DDA0288CQ35158137-71953374-94CA-40D4-BA6E-5500F835CE7AQ35234286-2D75459E-DD19-46B6-8B5E-2E9BF0ECB264
P2860
Screening for prostate cancer--the controversy that refuses to die.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Screening for prostate cancer--the controversy that refuses to die.
@en
Screening for prostate cancer--the controversy that refuses to die.
@nl
type
label
Screening for prostate cancer--the controversy that refuses to die.
@en
Screening for prostate cancer--the controversy that refuses to die.
@nl
prefLabel
Screening for prostate cancer--the controversy that refuses to die.
@en
Screening for prostate cancer--the controversy that refuses to die.
@nl
P356
P1476
Screening for prostate cancer--the controversy that refuses to die.
@en
P2093
Michael J Barry
P304
P356
10.1056/NEJME0901166
P407
P577
2009-03-18T00:00:00Z